However, the molecular mechanisms underlying CARM1 regulation of breast cancer development remain incompletely understood, which is partially due to the lack of genomic, transcriptomic and proteomic characterization of CARM1 chromatin-binding sites, transcriptional targets and methylation substrates in a systematic way. Here, CARM1 is linked to breast cancer.